Ultrasmall magnolol/ebselen nanomicelles for preventing renal ischemia/reperfusion injury-Reference-Cited by-同舟云学术

Ultrasmall magnolol/ebselen nanomicelles for preventing renal ischemia/reperfusion injury

Published:2024 Issue:17 Volume:12 Page:4407-4426
ISSN:2047-4830
Container-title:Biomaterials Science
language:en
Short-container-title:Biomater. Sci.

Author:

Liu Chang¹,Li Linhua¹^ORCID,Li Li²,Li Qingyin³,Liu Jing¹,Zhang Chunle¹,Cao Zhengjiang¹,Ma Liang¹^ORCID,Zeng Xiaoxi¹,Fu Ping¹^ORCID

Affiliation:

1. Department of Nephrology, Institute of Kidney Diseases, West China Hospital of Sichuan University, Chengdu 610041, China

2. Institute of Clinical Pathology, West China Hospital of Sichuan University, Chengdu, 610041, China

3. Department of Nephrology, Institute of Kidney Diseases, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China

Abstract

An illustration of the preparation strategy and diverse biological functions of MG/EBS-Ms. (a) Preparation strategy of MG/EBS-Ms. (b) Schematic representation of the therapeutic role played by MG/EBS-Ms in renal I/R injury.

Funder

Sichuan Province Science and Technology Support Program

Postdoctoral Research Foundation of China

National Key Research and Development Program of China

West China Hospital, Sichuan University

Publisher

Royal Society of Chemistry (RSC)

Link

http://pubs.rsc.org/en/content/articlepdf/2024/BM/D4BM00614C

Reference69 articles.

1. Acute Kidney Failure: Current Challenges and New Perspectives

2. Incidence, Outcomes, and Comparisons across Definitions of AKI in Hospitalized Individuals

3. Incidence and outcomes of AKI in postoperative patients admitted to ICU using full KDIGO criteria – a cohort study

4. Biomarkers in acute kidney injury: On the cusp of a new era?

5. Clinical Analysis of Cause, Treatment and Prognosis in Acute Kidney Injury Patients